Alterations in The Plasma Expression of mir-15b, mir-195 and the Tumor-Suppressor Gene DLEU7 in Patients with B-Cell Chronic Lymphocytic Leukemia | Zendy

Malihe Bagheri | Zendy; Behzad Khansarinejad | Zendy; Ghasem Mosayebi | Zendy; Alireza Moradabadi | Zendy; Mahdieh Mondanizadeh | Zendy

Open Access

Alterations in The Plasma Expression of mir-15b, mir-195 and the Tumor-Suppressor Gene DLEU7 in Patients with B-Cell Chronic Lymphocytic Leukemia

Author(s) -

Malihe Bagheri,

Behzad Khansarinejad,

Ghasem Mosayebi,

Alireza Moradabadi,

Mahdieh Mondanizadeh

Publication year - 2021

Publication title -

reports of biochemistry and molecular biology

Language(s) - English

Resource type - Journals

ISSN - 2322-3480

DOI - 10.52547/rbmb.10.1.20

Subject(s) - microrna , chronic lymphocytic leukemia , gene , pathogenesis , gene expression , leukemia , cancer research , suppressor , biology , immunology , medicine , genetics

Chronic lymphocytic leukemia (CLL) is one of the most prevalent forms of leukemia in adults. Inactivation of the DLEU7 gene is frequently observed in patients with CLL. Furthermore, microRNAs (miRNAs) have been observed to have a critical role in the pathogenesis of several cancers, including leukemia. Considering the tumor-suppressive role of DLEU7, as well as the tumor suppressor or oncogenic role of microRNAs (miRNAs), the aim of the present study was to evaluate the potential miRNAs targeting the DLEU7 gene in B-cells and explore expression changes these genes in the plasma of B-CLL patients.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research